Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Childhood Asthma Research and Education (CARE) network trial: Treating Children to Prevent Exacerbations of Asthma (TREXA).

X
Trial Profile

Childhood Asthma Research and Education (CARE) network trial: Treating Children to Prevent Exacerbations of Asthma (TREXA).

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 14 Jan 2020

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Beclometasone (Primary) ; Salbutamol (Primary) ; Corticosteroids
  • Indications Asthma
  • Focus Therapeutic Use
  • Acronyms TREXA
  • Most Recent Events

    • 23 May 2012 Stratified results presented at the 108th International Conference of the American Thoracic Society.
    • 28 Dec 2011 Actual end date changed from Feb 2010 to Dec 2011 as reported by ClinicalTrials.gov.
    • 26 Apr 2011 Planned End Date changed from 1 May 2010 to 1 Jan 2012 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top